Connor, Clark & Lunn Investment Management (CC&L)’s Abeona Therapeutics ABEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,297
| Closed | -$404K | – | 971 |
|
|
2020
Q4 | $404K | Buy |
10,297
+1,527
| +17% | +$59.9K | ﹤0.01% | 751 |
|
|
2020
Q3 | $224K | Sell |
8,770
-2,664
| -23% | -$68K | ﹤0.01% | 829 |
|
|
2020
Q2 | $833K | Buy |
11,434
+2,782
| +32% | +$203K | 0.01% | 657 |
|
|
2020
Q1 | $454K | Buy |
8,652
+7,307
| +543% | +$383K | ﹤0.01% | 717 |
|
|
2019
Q4 | $110K | Buy |
1,345
+404
| +43% | +$33K | ﹤0.01% | 876 |
|
|
2019
Q3 | $53K | Buy |
+941
| New | +$53K | ﹤0.01% | 933 |
|